about
Deletion of ultraconserved elements yields viable miceGenomic views of distant-acting enhancersGenePaint.org: an atlas of gene expression patterns in the mouse embryoUltraconservation identifies a small subset of extremely constrained developmental enhancersDisruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lipVISTA Enhancer Browser--a database of tissue-specific human enhancersGenome-wide atlas of gene expression in the adult mouse brainFunctional anatomy of distant-acting mammalian enhancersChIP-seq accurately predicts tissue-specific activity of enhancersChIP-Seq identification of weakly conserved heart enhancersThe Epigenomic Landscape of ProkaryotesScaffolding by ERK3 regulates MK5 in developmentMetagenomic discovery of biomass-degrading genes and genomes from cow rumenFine tuning of craniofacial morphology by distant-acting enhancersSubpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate.Regulatory pathway analysis by high-throughput in situ hybridization.Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancersMultiple conserved regulatory domains promote Fezf2 expression in the developing cerebral cortex.Function-based identification of mammalian enhancers using site-specific integration.Tissue-specific SMARCA4 binding at active and repressed regulatory elements during embryogenesis.52 Genetic Loci Influencing Myocardial Mass.Transcriptional regulation of enhancers active in protodomains of the developing cerebral cortexTargeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.Tissue-specific RNA expression marks distant-acting developmental enhancers.Methane yield phenotypes linked to differential gene expression in the sheep rumen microbiome.The FaceBase Consortium: a comprehensive program to facilitate craniofacial research.Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variantsDisruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions.Differences in enhancer activity in mouse and zebrafish reporter assays are often associated with changes in gene expression.Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease.Use of "MGE enhancers" for labeling and selection of embryonic stem cell-derived medial ganglionic eminence (MGE) progenitors and neurons.Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factorsDe novo transcriptome assembly of drought tolerant CAM plants, Agave deserti and Agave tequilana.Transcriptional control of axonal guidance and sorting in dorsal interneurons by the Lim-HD proteins Lhx9 and Lhx1.Limits of sequence and functional conservation.Principles of regulatory information conservation between mouse and human.HAND2 targets define a network of transcriptional regulators that compartmentalize the early limb bud mesenchyme.Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence.Occupancy by key transcription factors is a more accurate predictor of enhancer activity than histone modifications or chromatin accessibility.Genomic perspectives of transcriptional regulation in forebrain development.
P50
Q21092753-804C4393-9A7F-460A-9611-C0969599C4FBQ22122210-FB82C022-4D9F-4297-9D9A-969FF16D17CBQ24600734-3A738CC3-5589-4037-8E6B-45CF7A78DBF8Q24648269-71826F8E-901B-4892-8F82-6B036DB9EEDFQ24650690-107579B6-D3A2-4148-A7DF-01E28C535D38Q24676452-029DF09C-1BE5-4F9E-9CE9-5455F60976ABQ26253934-DC2BE342-77D1-4218-A941-2BA5DAA6094EQ27005836-9364694A-793A-4BA3-A69E-B6957B9D6645Q28235102-5CA7CDE3-82ED-4014-9A1C-4364ED5048DEQ28291198-2D2D6C11-8EAD-4468-803B-936B98FD45C5Q28550136-E462AACA-C5D9-4DF9-B755-8C64BEC98AE8Q28587317-916F1F89-F2AE-430C-B78F-A09AAE393B0DQ29618058-A32B33F0-2AF5-4E39-92DB-0EAF772123DFQ30576356-2A4556EE-AAB6-4229-B2C3-5B3DB10F3578Q31135205-0BE09E28-DF2F-4646-974A-AEFB89F22F96Q33303447-5C4D37CC-60A8-4ECB-91B3-FECBCB5A7C3BQ33549139-C3976714-3070-4C2E-B7C2-602C1240A5DBQ33559010-EBA49476-CD94-4A9A-BFBE-517F4F01AB19Q33559746-3D26BC45-8F93-44AA-9C04-32F383448EDBQ33657733-58E542C9-0202-46D8-9AFA-FDD027E056A9Q33817558-236D738D-49E9-4D47-BEB7-AD137C08AB8AQ33925320-FB097893-2C00-43CF-AE3F-43D470C96886Q34121996-557804DC-E1BB-4947-8B2F-C03AB72F81C3Q34133708-21C69B6C-6A9C-4529-8414-99068D2E2C27Q34153777-747277CD-99ED-4FD4-9493-72C4FB5EC80AQ34175114-03604691-ECB4-4E22-9267-195EC352C8E9Q34377776-C0C943D4-583B-4766-BFBB-D47D7A398ACAQ34475839-5CA4450D-1008-4122-B35A-69275084AC57Q34518186-F94F77C0-133A-44AA-8B9B-6DCB271CD5C5Q34536097-F3283FBC-1CD0-43FC-B813-22F9A7890106Q34712389-1AF33160-39B4-4D07-BA93-D73D0EFD5123Q34900031-64FA84FA-35A8-4656-A0F9-517C2E59854DQ34955897-7828A0D2-4A80-4649-9965-A6CC48026D18Q34988217-31F3E165-3FA6-432F-B0D3-EA813754E4B1Q35126344-1FBB20CC-DFEB-40FF-A50C-2FAE945814F4Q35128631-43CB27B7-225E-4FE9-8559-F5D7D63C71A8Q35170396-157AF600-E7EC-4CB8-9076-D6DCEFA627C8Q35318805-F6DCD5ED-42A8-41B8-8B08-C27CEF4758B8Q35608650-C34F7C29-C235-400F-ABCC-E057EFD9B9A4Q35627595-6EBF3219-256E-49D1-84A3-C45272E2BEDF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Axel Visel
@ast
Axel Visel
@en
Axel Visel
@es
Axel Visel
@nl
Axel Visel
@sl
type
label
Axel Visel
@ast
Axel Visel
@en
Axel Visel
@es
Axel Visel
@nl
Axel Visel
@sl
prefLabel
Axel Visel
@ast
Axel Visel
@en
Axel Visel
@es
Axel Visel
@nl
Axel Visel
@sl
P1053
A-9398-2009
P106
P1153
6507604387
P21
P31
P3829
P496
0000-0002-4130-7784